{"id":7695,"date":"2022-02-15T09:37:39","date_gmt":"2022-02-15T08:37:39","guid":{"rendered":"https:\/\/irlab.se\/?page_id=7695"},"modified":"2026-01-13T14:27:08","modified_gmt":"2026-01-13T13:27:08","slug":"startsida","status":"publish","type":"page","link":"https:\/\/irlab.se\/sv\/","title":{"rendered":"Startsida"},"content":{"rendered":"\n
\"\"<\/span>
\n
\n
\n
<\/div>\n\n\n\n

Att f\u00f6r\u00e4ndra livet f\u00f6r personer som lever med Parkinson och andra CNS sjukdomar<\/h1>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n
<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n
\"\"<\/span>
\n
<\/div>\n\n\n\n

Att f\u00f6r\u00e4ndra livet f\u00f6r personer som lever med Parkinson och andra CNS sjukdomar<\/h1>\n<\/div><\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
\n\n
\n SENASTE PRESSMEDDELANDET<\/span>\n <\/div>\n \n
\n\n \n 17 APRIL 2026 \/ REGULATORISK<\/span>\n <\/span>\n\n

Valberedningens f\u00f6rslag till styrelse inf\u00f6r IRLAB Therapeutics \u00e5rsst\u00e4mman 2026<\/h3>\n\n

G\u00f6teborg den 17 april 2026 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelar idag att valberedningen inf\u00f6r \u00e5rsst\u00e4mman 2026 f\u00f6resl\u00e5r val av Jan-Fredrik Backman som ny vice styrelseordf\u00f6rande samt James Gamgort som ny styrelseledamot. Valberedningen f\u00f6resl\u00e5r vidare omval av styrelseordf\u00f6rande Carola Lemne samt styrelseledam\u00f6terna Gunnar Olsson, Rein Piir och Veronica Wallin. Christer Nordstedt har avb\u00f6jt omval.<\/p>\n \n\n L\u00e4s mer ><\/a>\n <\/div>\n \n \n \n <\/div>\n<\/div><\/div>\n\n\n\n

\n
\n
\n
\n
IRLAB A<\/div>\n
1.482<\/div>\n
SEK<\/div>\n\n <\/div>\n\n
\n
\n
\n
TODAY<\/div>\n
-2.50 %<\/div>\n <\/div>\n\n
\n
TODAY SEK<\/div>\n
-0.04 SEK<\/div>\n\n <\/div>\n\n
\n
16:00:00<\/div>\n
2026-04-22<\/div>\n <\/div>\n <\/div>\n Mer om aktien ><\/a>\n <\/div>\n\n <\/div>\n\n<\/div>\n\n <\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

ISP – IRLAB:s unika och egenutvecklade teknikplattform<\/h2>\n\n\n\n

IRLAB:s unika och resurseffektiva forskningsmetod kallad Integrative Screening Process (ISP) genererar bolagets l\u00e4kemedelskandidater. Denna egenutvecklade plattform \u00e4r byggd ett p\u00e5 systembiologiskt syns\u00e4tt med en omfattande, standardiserad, och v\u00e4rldsunik databas \u00f6ver CNS-substanser och klasser som samlats in under 25 \u00e5rs forskning.<\/p>\n\n\n\n

\n
L\u00e4s mer om ISP ><\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
<\/span>
\n
\n
\n

IRLAB:s TV\u00c5 L\u00c4KEMEDELSKANDIDATER I KLINISK FAS II<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

Mesdopetam (IRL790)<\/h2>\n\n\n\n

Utvecklas f\u00f6r att behandla levodopa-inducerad dyskinesi (LIDs), dvs ofrivilliga \u00f6verr\u00f6relser som uppkommer efter l\u00e5ngtidsbehandling med levodopa vid Parkinsons sjukdom.<\/p>\n\n\n\n

\n
L\u00e4s mer om mesdopetam ><\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n

Pirepemat (IRL752)<\/h2>\n\n\n\n

Utvecklas f\u00f6r att behandla och minska risken f\u00f6r fall och fallolyckor vid Parkinsons sjukdom.<\/p>\n\n\n\n

\n
L\u00e4s mer om pirepemat ><\/a><\/div>\n<\/div>\n\n\n\n

<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n
\n
\n
\n SENASTE PRESENTATIONEN <\/div>\n \n
\n \n\t\t\t\t\t\t\t\t\t14 APRIL 2026 \t\t\t\t\t\t\t\t<\/span>\n

Kristina Torfg\u00e5rd, CEO, presenterar p\u00e5 Redeye Healthcare Day<\/h3>\n\n

Kristina Torfg\u00e5rd, CEO, presenterade p\u00e5 Redeyes Healthcare Day den 14 april 2026.<\/p>\n\n L\u00e4s mer ><\/a>\n <\/div>\n\n \n\n \n <\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

ISP – IRLAB:s unika och egenutvecklade teknikplattform IRLAB:s unika och resurseffektiva forskningsmetod kallad Integrative Screening Process (ISP) genererar bolagets l\u00e4kemedelskandidater. Denna egenutvecklade plattform \u00e4r byggd ett p\u00e5 systembiologiskt syns\u00e4tt med en omfattande, standardiserad, och v\u00e4rldsunik databas \u00f6ver CNS-substanser och klasser som samlats in under 25 \u00e5rs forskning.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page__homepage.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-7695","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nStartsida - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Startsida - IRLAB\" \/>\n<meta property=\"og:description\" content=\"ISP – IRLAB:s unika och egenutvecklade teknikplattform IRLAB:s unika och resurseffektiva forskningsmetod kallad Integrative Screening Process (ISP) genererar bolagets l\u00e4kemedelskandidater. Denna egenutvecklade plattform \u00e4r byggd ett p\u00e5 systembiologiskt syns\u00e4tt med en omfattande, standardiserad, och v\u00e4rldsunik databas \u00f6ver CNS-substanser och klasser som samlats in under 25 \u00e5rs forskning.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-13T13:27:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/irlab.se\/wp-content\/uploads\/2024\/10\/Irlab_start_2_web-1024x495.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"495\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/\",\"url\":\"https:\/\/irlab.se\/sv\/\",\"name\":\"Startsida - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/irlab.se\/sv\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/irlab.se\/sv\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/irlab.se\/wp-content\/uploads\/2024\/10\/Irlab_start_2_web.png\",\"datePublished\":\"2022-02-15T08:37:39+00:00\",\"dateModified\":\"2026-01-13T13:27:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\/\/irlab.se\/sv\/#primaryimage\",\"url\":\"https:\/\/irlab.se\/wp-content\/uploads\/2024\/10\/Irlab_start_2_web.png\",\"contentUrl\":\"https:\/\/irlab.se\/wp-content\/uploads\/2024\/10\/Irlab_start_2_web.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Startsida\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Startsida - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/","og_locale":"sv_SE","og_type":"article","og_title":"Startsida - IRLAB","og_description":"ISP – IRLAB:s unika och egenutvecklade teknikplattform IRLAB:s unika och resurseffektiva forskningsmetod kallad Integrative Screening Process (ISP) genererar bolagets l\u00e4kemedelskandidater. Denna egenutvecklade plattform \u00e4r byggd ett p\u00e5 systembiologiskt syns\u00e4tt med en omfattande, standardiserad, och v\u00e4rldsunik databas \u00f6ver CNS-substanser och klasser som samlats in under 25 \u00e5rs forskning.","og_url":"https:\/\/irlab.se\/sv\/","og_site_name":"IRLAB","article_modified_time":"2026-01-13T13:27:08+00:00","og_image":[{"width":1024,"height":495,"url":"https:\/\/irlab.se\/wp-content\/uploads\/2024\/10\/Irlab_start_2_web-1024x495.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/","url":"https:\/\/irlab.se\/sv\/","name":"Startsida - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"primaryImageOfPage":{"@id":"https:\/\/irlab.se\/sv\/#primaryimage"},"image":{"@id":"https:\/\/irlab.se\/sv\/#primaryimage"},"thumbnailUrl":"https:\/\/irlab.se\/wp-content\/uploads\/2024\/10\/Irlab_start_2_web.png","datePublished":"2022-02-15T08:37:39+00:00","dateModified":"2026-01-13T13:27:08+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/irlab.se\/sv\/#primaryimage","url":"https:\/\/irlab.se\/wp-content\/uploads\/2024\/10\/Irlab_start_2_web.png","contentUrl":"https:\/\/irlab.se\/wp-content\/uploads\/2024\/10\/Irlab_start_2_web.png"},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"Startsida"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/7695","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=7695"}],"version-history":[{"count":79,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/7695\/revisions"}],"predecessor-version":[{"id":12779,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/7695\/revisions\/12779"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=7695"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}